Protalix BioTherapeutics, Inc. - PLX
All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)?
Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).
Files summary
Total files loaded: 8
Latest filed: Aug 12, 2026
| Form | Count |
|---|---|
| 8-K | 6 |
| SCHEDULE 13G/A | 1 |
| SCHEDULE 13G | 1 |
Latest files
| Filed | Form | Report period | Accession | SEC |
|---|---|---|---|---|
| Aug 12, 2026 | 8-K | Aug 12, 2026 | 0001104659-26-094433 | View |
| Jun 25, 2026 | 8-K | Jun 25, 2026 | 0001104659-26-077790 | View |
| May 21, 2026 | 8-K | May 21, 2026 | 0001104659-26-064850 | View |
| May 13, 2026 | 8-K | May 13, 2026 | 0001104659-26-059749 | View |
| Mar 30, 2026 | SCHEDULE 13G/A | — | 0001426156-26-000006 | View |
| Mar 18, 2026 | 8-K | Mar 18, 2026 | 0001104659-26-029846 | View |
| Mar 09, 2026 | 8-K | Mar 09, 2026 | 0001104659-26-024975 | View |
| Mar 04, 2026 | SCHEDULE 13G | — | 0001426156-26-000002 | View |